glutamine has been researched along with Activated Protein C Resistance in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacob, D; Loew, A; Neuhaus, P; Riess, H | 1 |
| Adamzik, M; Frey, UH; Lehmann, N; Peters, J; Riemann, K; Siffert, W; Sixt, S | 1 |
| Chi, HS; Kim, SB; Kim, SH; Kim, SW; Kim, TW; Kim, WK; Lee, JH; Lee, JS; Lee, KH; Seo, EJ; Suh, C | 1 |
| Dahlbäck, B | 1 |
1 review(s) available for glutamine and Activated Protein C Resistance
| Article | Year |
|---|---|
Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
Topics: Activated Protein C Resistance; Arginine; Factor V; Glutamine; Humans; Point Mutation; Thrombophilia; Thrombosis | 1999 |
3 other study(ies) available for glutamine and Activated Protein C Resistance
| Article | Year |
|---|---|
Resistance to activated protein C caused by factor V Leiden mutation and orthotopic liver transplantation.
Topics: Activated Protein C Resistance; Adult; Aged; Factor V; Female; Gene Frequency; Glutamine; Heterozygote; Humans; Incidence; Liver Transplantation; Male; Medical Records; Middle Aged; Mutation; Risk Factors; Survival Analysis; Thromboembolism; Venous Thrombosis | 2005 |
Factor V Leiden mutation is associated with improved 30-day survival in patients with acute respiratory distress syndrome.
Topics: Activated Protein C Resistance; Adult; APACHE; Arginine; Cohort Studies; Factor V; Female; Genotype; Glutamine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Point Mutation; Polymorphism, Single Nucleotide; Respiratory Distress Syndrome; Retrospective Studies | 2008 |
Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
Topics: Activated Protein C Resistance; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Arginine; Factor V; Glutamine; Humans; Korea; Middle Aged; Point Mutation; Prevalence; Venous Thrombosis | 1998 |